Wall Street further embraced Abbott Laboratories as it beat expectations and raised its 2019 guidance. Investors doubled down on the prospects for the med-tech company to outperform its large cap peers, pushing shares (NYSE:ABT) up by 5% in the wake of its June 17 earnings announcement. Read More
With the ongoing push toward value-based care, providers are looking for ways to improve patient outcomes while also lowering health care costs. Los Angeles-based Dearhealth Inc.'s artificial intelligence-powered software-as-a-service (SaaS) platform aims to do meet that demand by helping physicians better manage patients with chronic conditions. Now Philips Health Technology Ventures and other large investors are putting their money behind the company, seeing an opportunity to generate real movement in advance population health. Read More
